(Total Views: 410)
Posted On: 07/28/2020 10:11:23 AM
Post# of 208
Therapeutic Solutions International Files Patent on Ability of QuadraMune Ingredient Pterostilbene to Reduce Inflammation while Stimulating Brain Protective Biological Pathways
Mechanistic Studies Continuing on QuadraMuneâ„¢ a COVID19 Candidate in Clinical Trial
Company Continues Quest to Dominate Intellectual Property Regarding COVID-19 Associated Pathologies
https://www.prnewswire.com/news-releases/ther...01258.html
Mechanistic Studies Continuing on QuadraMuneâ„¢ a COVID19 Candidate in Clinical Trial
Company Continues Quest to Dominate Intellectual Property Regarding COVID-19 Associated Pathologies
https://www.prnewswire.com/news-releases/ther...01258.html
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)